Center for Inherited Blood Disorders (CIBD) Site Number : 8400016 — Orange, California

Center for Inherited Blood Disorders (CIBD) Site Number : 8400016 is a clinical research site located in Orange, California, United States 92868.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Center for Inherited Blood Disorders (CIBD) Site Number : 8400016 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Hemophilia.

Sponsors: Genzyme, a Sanofi Company.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Orange

Browse all research sites in California · View every site in Orange

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Center for Inherited Blood Disorders (CIBD) Site Number : 8400016?

Center for Inherited Blood Disorders (CIBD) Site Number : 8400016 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Center for Inherited Blood Disorders (CIBD) Site Number : 8400016 conducted?

Center for Inherited Blood Disorders (CIBD) Site Number : 8400016 has 1 clinical trials on record, with 1 currently active. Their work covers Hemophilia.

Is Center for Inherited Blood Disorders (CIBD) Site Number : 8400016 accredited by Crixeo Clinical Trials?

Center for Inherited Blood Disorders (CIBD) Site Number : 8400016 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Center for Inherited Blood Disorders (CIBD) Site Number : 8400016?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.